Kinetics of SARS-CoV-2-Neutralising Antibodies of Residents of Long-Term Care Facilities
Authors:
Open Access
- 1 January 2022
- journal article
- research article
- Published by Elsevier in The Journal of nutrition, health and aging
- Vol. 26 (1) , 57-63
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Potential lethal outbreak of coronavirus disease (COVID-19) among the elderly in retirement homes and long-term facilities, France, March 2020Eurosurveillance, 2020
- Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, ChinaClinical Infectious Diseases, 2020
- Immune Responses to Middle East Respiratory Syndrome Coronavirus During the Acute and Convalescent Phases of Human InfectionClinical Infectious Diseases, 2018
- The CD8 T Cell Response to Respiratory Virus InfectionsFrontiers in Immunology, 2018
- The Role of Immunosenescence in the Development of Age-Related DiseasesRevista de Investigación Clínica, 2016
- Murine Leukemia Virus (MLV)-based Coronavirus Spike-pseudotyped Particle Production and InfectionBio-Protocol, 2016
- The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20–100 years of ageBiogerontology, 2008
- The immune risk phenotype is associated with IL-6 in the terminal decline stage: Findings from the Swedish NONA immune longitudinal study of very late life functioningMechanisms of Ageing and Development, 2006
- A global clinical measure of fitness and frailty in elderly peopleCanadian Medical Association Journal, 2005
- An Immune Risk Phenotype, Cognitive Impairment, and Survival in Very Late Life: Impact of Allostatic Load in Swedish Octogenarian and Nonagenarian HumansThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2005